Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial

Ruth Webster, Stephen Ch Li, David R Sullivan, Kathy Jayne, Steve Ys Su, Bruce Neal, Ruth Webster, Stephen Ch Li, David R Sullivan, Kathy Jayne, Steve Ys Su, Bruce Neal

Abstract

Background: Elevated low-density lipoprotein (LDL) cholesterol is a leading risk factor for cardiovascular disease. Despite the availability of proven interventions to lower LDL cholesterol, their use remains subobtimal. Many websites provide interactive, tailored advice on cardiovascular risk in an attempt to help bridge this evidence-practice gap, yet there is little evidence that provision of such a tool is effective in changing practice.

Objectives: The objective was to define the effects on use of cholesterol-lowering interventions of a consumer-targeted tailored advice website.

Methods: This was a prospective, double-blind, randomized controlled trial open to any adult Australian with access to the Internet. A total of 2099 participants were randomized. Of these, 45% were male, the mean age of all participants was 56, and 1385 (66%) self-reported hypercholesterolemia. Follow-up information was obtained for 1945 (93%). Participants completed a brief online questionnaire. Individuals assigned to intervention received immediate, fully automated, personally tailored advice (based on current guidelines) regarding the need for commencement of statin therapy, increased statin therapy in those already on treatment, and nondrug intervention strategies. Control group participants were directed to static Web pages providing general information about cholesterol management.

Results: The primary outcome was the proportion of participants that commenced or increased use of prescribed cholesterol-lowering therapy. Of the total 2099 randomized participants, 304 (14%) met eligibility criteria for cholesterol-lowering therapy but were not prescribed treatment, and 254 (12%) were prescribed treatment but were not achieving the recommended target level. Treatment was commenced or increased in 64 (6.0%) of the 1062 intervention group participants and 79 (7.6%) of the 1037 control group participants (% difference = -1.6%, 95% confidence interval [CI] -3.75 to 0.57, P = .15). No differences were found between the randomized groups for the secondary outcomes of "discussed treatment with a health professional" (% difference = -3.8%, 95% confidence interval [CI] -8.16 to 0.19, P = .08), "had their cholesterol checked" (% difference = -1.5%, 95% CI -5.79 to 2.71, P = .48), "had their blood pressure checked" (% difference = 1.4%, 95% CI -2.55 to 5.34, P = .49) or made a lifestyle change (P values between .49 and .96).

Conclusions: Despite providing specific carefully tailored advice, this website had no detectable effect on cholesterol management strategies. This finding raises considerable uncertainty about the value of Internet-based tools providing tailored advice directly to consumers.

Trial registration: NCT00220974; https://ichgcp.net/clinical-trials-registry/NCT00220974 (Archived by WebCite at http://www.webcitation.org/5sdq63rrY).

Conflict of interest statement

None declared

Figures

Figure 1
Figure 1
Screenshot of sample tailored advice
Figure 2
Figure 2
Flow chart

References

    1. Expert Panel on Detection, Evaluation, and Treatment, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA. 2001 May 16;285(19):2486–97.jsc10094
    1. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen L, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); WONCA Europe (European Society of General Practice/Family Medicine); European Heart Network (EHN); European Atherosclerosis Society (EAS) European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur J Cardiovasc Prev Rehabil. 2007 Sep;14(Suppl 2):S1–113. doi: 10.1097/01.hjr.0000277983.23934.c9. 00149831-200709001-00002
    1. Tonkin A, Barter P, Best J, Boyden A, Furler J, Hossack K, Sullivan D, Thompson P, Vale M, Cooper C, Robinson M, Clune E, National Heart Foundation of Australia. Cardiac Society of Australia and New Zealand National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005. Heart Lung Circ. 2005 Dec;14(4):275–91. doi: 10.1016/j.hlc.2005.10.010.S1443-9506(05)00216-7
    1. Schwartz JS. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Comparative economic data regarding lipid-lowering drugs. Am Heart J. 1999 May;137(5):S97–104.S0002870399001696
    1. Szucs TD. Pharmaco-economic aspects of lipid-lowering therapy: is it worth the price? Eur Heart J. 1998 Oct;19(Suppl M):M22–8.
    1. Kemp TM, Barr EL, Zimmet PZ, Cameron AJ, Welborn TA, Colagiuri S, Phillips P, Shaw JE. Glucose, lipid, and blood pressure control in Australian adults with type 2 diabetes: the 1999-2000 AusDiab. Diabetes Care. 2005 Jun;28(6):1490–2. 28/6/1490
    1. Vale MJ, Jelinek MV, Best JD COACH study group. Coaching patients on Achieving Cardiovascular Health. How many patients with coronary heart disease are not achieving their risk-factor targets? Experience in Victoria 1996-1998 versus 1999-2000. Med J Aust. 2002 Mar 4;176(5):211–5. val10572
    1. Webster R, Heeley E, Bayram C, Patel A. Blood pressure and lipid management in Australian general practice--Are guidelines being implemented? Heart Lung Circ. 2007;16(Supplement 2):S195–S196.
    1. Skinner CS, Campbell MK, Rimer BK, Curry S, Prochaska JO. How effective is tailored print communication? Ann Behav Med. 1999;21(4):290–8.
    1. Portnoy DB, Scott-Sheldon LA, Johnson BT, Carey MP. Computer-delivered interventions for health promotion and behavioral risk reduction: a meta-analysis of 75 randomized controlled trials, 1988-2007. Prev Med. 2008 Jul;47(1):3–16. doi: 10.1016/j.ypmed.2008.02.014. S0091-7435(08)00101-1
    1. Burns E. ClickZ. 2008. Sep, Active Home Internet Users by Country .
    1. Fox S. Online Health Search 2006. Washington, DC: Pew Internet & American Life Project; 2006. .
    1. Murray E, Burns J, See TS, Lai R, Nazareth I. Interactive Health Communication Applications for people with chronic disease. Cochrane Database Syst Rev. 2005;(4):CD004274. doi: 10.1002/14651858.CD004274.pub4.
    1. Kroeze W, Werkman A, Brug J. A systematic review of randomized trials on the effectiveness of computer-tailored education on physical activity and dietary behaviors. Ann Behav Med. 2006 Jun;31(3):205–23. doi: 10.1207/s15324796abm3103_2.
    1. Kreuter MW, Strecher VJ. Do tailored behavior change messages enhance the effectiveness of health risk appraisal? Results from a randomized trial. Health Educ Res. 1996 Mar;11(1):97–105.
    1. Bennett M. . 2005. A risk score for cardiovascular disease
    1. Siteman Cancer Center. 2007. Your Disease Risk: the source on prevention
    1. Spittaels H, De Bourdeaudhuij I, Brug J, Vandelanotte C. Effectiveness of an online computer-tailored physical activity intervention in a real-life setting. Health Educ Res. 2007 Jun;22(3):385–96. doi: 10.1093/her/cyl096. cyl096
    1. Yardley L, Nyman SR. Internet provision of tailored advice on falls prevention activities for older people: a randomized controlled evaluation. Health Promot Int. 2007 Jun;22(2):122–8. doi: 10.1093/heapro/dam007. dam007
    1. Slootmaker SM, Chinapaw MJ, Schuit AJ, Seidell JC, Van Mechelen W. Feasibility and effectiveness of online physical activity advice based on a personal activity monitor: randomized controlled trial. J Med Internet Res. 2009;11(3):e27. doi: 10.2196/jmir.1139. v11i3e27
    1. Strecher VJ, McClure J, Alexander G, Chakraborty B, Nair V, Konkel J, Greene S, Collins L, Carlier C, Wiese C, Little R, Pomerleau C, Pomerleau O. Web-based smoking-cessation programs: results of a randomized trial. Am J Prev Med. 2008 May;34(5):449–50. doi: 10.1016/j.amepre.2007.12.024. S0749-3797(08)00150-5
    1. Australian Government Department of Health and Ageing. 2004. Pharmaceutical Benefit Scheme .
    1. National Heart Foundation of Australia; Cardiac Society of Australia and New Zealand. Lipid management guidelines--2001. National Heart Foundation of Australia, The Cardiac Society of Australia and New Zealand. Med J Aust. 2001 Nov 5;175 Suppl:S57–85.
    1. Law M. Plant sterol and stanol margarines and health. BMJ. 2000 Mar 25;320(7238):861–4.
    1. The George Institute for International Health. 2005. The Internet-Based Cholesterol Assessment Trial .
    1. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol. 1992 Sep;47(9):1102–14.
    1. Webb TL, Joseph J, Yardley L, Michie S. Using the internet to promote health behavior change: a systematic review and meta-analysis of the impact of theoretical basis, use of behavior change techniques, and mode of delivery on efficacy. J Med Internet Res. 2010;12(1):e4. doi: 10.2196/jmir.1376. v12i1e4
    1. Grol R, Wensing M. What drives change? Barriers to and incentives for achieving evidence-based practice. Med J Aust. 2004 Mar 15;180(6 Suppl):S57–60. gro10753_fm
    1. Newnham GM, Burns WI, Snyder RD, Dowling AJ, Ranieri NF, Gray EL, McLachlan SA. Attitudes of oncology health professionals to information from the Internet and other media. Med J Aust. 2005 Aug 15;183(4):197–200. new10676_fm
    1. Kreuter MW, Strecher VJ, Glassman B. One size does not fit all: the case for tailoring print materials. Ann Behav Med. 1999;21(4):276–83.
    1. Van Maarle MC, Stouthard ME, Marang-Van De Mheen PJ, Klazinga NS, Bonsel GJ. Follow up after a family based genetic screening programme for familial hypercholesterolaemia: is screening alone enough? BMJ. 2002 Jun 8;324(7350):1367–8.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever